CAS 1434639-57-2

ND-646

CAS: 1434639-57-2

(R)-2-(1-(2-(2-Methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethyl)-5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-2-methylpropanamide

Formula: C₂₈H₃₂N₄O₇S

Purity: 99%

Molecular weight: 568.64

Ref: IN-DG00795853

ND-646

CAS: 1434639-57-2

ND-646

Formula: C₂₈H₃₂N₄O₇S

Purity: ≥98%

Molecular weight: 568.64

Ref: 54-BUP04658

1,4-Dihydro-1-[(2R)-2-(2-methoxyphenyl)-2-[(tetrahydro-2H-pyran-4-yl)oxy]ethyl]-α,α,5-trimethyl-6-(2-oxazolyl)-2,4-dioxothieno[2,3-d]pyrimidine-3(2H)-acetamide

CAS: 1434639-57-2

Formula: C₂₈H₃₂N₄O₇S

Purity: 99%

Color and Shape: Solid

Molecular weight: 568.6413

Ref: IN-DA003AUN

ND-646

CAS: 1434639-57-2

ND-646 is an orally bioavailable and allosteric inhibitor of the ACC enzymes ACC1 and ACC2(IC50s of 3.5 nM and 4.1 nM for recombinant hACC1 and hACC2,

Formula: C₂₈H₃₂N₄O₇S

Purity: 98.64%

Color and Shape: Solid

Molecular weight: 568.64

Ref: TM-TQ0243

ND-646

CAS: 1434639-57-2

ND-646 is a drug for the treatment of bowel disease, cancer, and hepatic steatosis. It is an immunomodulatory drug that has been shown to reduce liver lesions in mice infected with infectious diseases and to inhibit tumor growth in animal models. ND-646 is a food supplement that contains essential nutrients and fatty acids. The chemical compound has been shown to have potential biomarker effects on the liver and inflammatory bowel disease. This product can be used as pharmaceutical preparations for humans or animals.

Formula: C₂₈H₃₂N₄O₇S

Purity: Min. 95%

Molecular weight: 568.64 g/mol

Ref: 3D-BN166809